Jack Lee has over 20 years of experience in oncology research and medical affairs. Currently serving as a Clinical Research Coordinator at Amgen since 2014, Jack focuses on clinical trial planning for soft tissue sarcomas, including Leiomyosarcoma, Liposarcoma, Pleomorphic sarcoma, and Rhabdomyosarcoma, while collaborating with prestigious institutions such as Mass General and Harvard Medical School. Prior to this role, Jack worked as a Global Medical Affairs Leader at AstraZeneca from 2003 to 2014 and as a Postdoctoral Scientist at Scripps Research from 1999 to 2003. Jack holds an MD in Oncology and Cancer Biology from Baylor College of Medicine and a BS in Molecular Biology from Vanderbilt University.
Org chart
This person is not in the org chart
Teams
Offices
Amgen
252 followers
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
